Sovaldi (sofosbuvir) Formulary Exception Coverage
Customize your policy alerts
Sign up for all venturacountyhealthcareplan policy alerts
Know when venturacountyhealthcareplan releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization and formulary exception requests for Sovaldi (sofosbuvir tablets and oral pellets) for chronic or recurrent hepatitis C virus infection in adult and pediatric patients when specified clinical, prior-treatment, specialist-prescriber, combination-therapy, cirrhosis, transplant, and treatment-duration criteria are met.
The policy history documents removal of Mavyret trial requirements from chronic genotype 3 adult criteria.
The policy history documents removal of Viekira and Viekira XR from the policy.
The policy history documents revisions requiring prior therapy trials and changing pediatric eligibility to patients at least 3 years of age.
The policy history documents removal of prior Sovaldi-with-Olysio approval criteria and removal of Olysio from the direct-acting antiviral combination exclusion statement.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.